Chromatin and epigenetic determinants of estrogen receptor alpha (ESR1) signaling

Molecular and Cellular Endocrinology

Volumn 382, Issue 1, 2014, Pages 633-641

  Magnani, Luca ^a,b,c,d   Lupien, Mathieu ^a,b,c  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b ONTARIO INSTITUTE FOR CANCER RESEARCH   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Chromatin; Epigenetic; Estrogen receptor; FOXA1; Pioneer factor; Transcriptional regulation

Indexed keywords

ESTROGEN RECEPTOR ALPHA; PROGESTERONE RECEPTOR; UNTRANSLATED RNA;

ARTICLE; BINDING SITE; BREAST CANCER; CHROMATIN; CHROMATIN STRUCTURE; EPIGENETICS; GENETICS; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

CHROMATIN; EPIGENETIC; ESTROGEN RECEPTOR; FOXA1; PIONEER FACTOR; TRANSCRIPTIONAL REGULATION;

CHROMATIN; CHROMATIN ASSEMBLY AND DISASSEMBLY; EPIGENESIS, GENETIC; ESTROGEN RECEPTOR ALPHA; HUMANS; PROTEIN BINDING; SIGNAL TRANSDUCTION;

EID: 84888330578     PISSN: 03037207     EISSN: 18728057     Source Type: Journal    
DOI: 10.1016/j.mce.2013.04.026     Document Type: Article

References (118)

1. Akhtar-Zaidi B., Cowper-Sal Lari R., Corradin O., Saiakhova A., Bartels C.F., Balasubramanian D., Myeroff L., Lutterbaugh J., Jarrar A., Kalady M.F., et al. Epigenomic enhancer profiling defines a signature of colon cancer. Science (New York, NY) 2012, 336:736-739. 10.1126/science.1217277.
2. Al-Dhaheri M., Wu J., Skliris G.P., Li J., Higashimato K., Wang Y., White K.P., Lambert P., Zhu Y., Murphy L., et al. CARM1 is an important determinant of ERα-dependent breast cancer cell differentiation and proliferation in breast cancer cells. Cancer Research 2011, 71:2118-2128. 10.1158/0008-5472.CAN-10-2426.
3. Barnett D.H., Sheng S., Charn T.H., Waheed A., Sly W.S., Lin C.-Y., Liu E.T., Katzenellenbogen B.S. Estrogen receptor regulation of carbonic anhydrase XII through a distal enhancer in breast cancer. Cancer Research 2008, 68:3505-3515. 10.1158/0008-5472.CAN-07-6151.
4. Baylin S.B., Jones P.A. A decade of exploring the cancer epigenome - biological and translational implications. Nature Reviews Cancer 2011, 11:726-734. 10.1038/nrc3130.
5. Bell O., Tiwari V.K., Thomä N.H., Schübeler D. Determinants and dynamics of genome accessibility. Nature Reviews Genetics 2011, 12:554-564. 10.1038/nrg3017.
6. Bilu Y., Barkai N. The design of transcription-factor binding sites is affected by combinatorial regulation. Genome Biology 2005, 6:R103. 10.1186/gb-2005-6-12-r103.
7. Bintu L., Ishibashi T., Dangkulwanich M., Wu Y.-Y., Lubkowska L., Kashlev M., Bustamante C. Nucleosomal elements that control the topography of the barrier to transcription. Cell 2012, 151:738-749. 10.1016/j.cell.2012.10.009.
8. Bonneville R., Jin V.X. A hidden Markov model to identify combinatorial epigenetic regulation patterns for estrogen receptor α target genes. Bioinformatics (Oxford, England) 2012, 10.1093/bioinformatics/bts639.
9. Bourdeau V. Genome-wide identification of high-affinity estrogen response elements in human and mouse. Molecular Endocrinology (Baltimore, Md.) 2004, 18:1411-1427. 10.1210/me.2003-0441.
10. Bretschneider N., Kangaspeska S., Seifert M., Reid G., Gannon F., Denger S. E2-mediated cathepsin D (CTSD) activation involves looping of distal enhancer elements. Molecular Oncology 2008, 2:182-190. 10.1016/j.molonc.2008.05.004.
11. Cancer Genome Atlas Network Comprehensive molecular portraits of human breast tumours. Nature 2012, 490:61-70. 10.1038/nature11412.
12. Carroll J.S., Liu X.S., Brodsky A.S., Li W., Meyer C.A., Szary A.J., Eeckhoute J., Shao W., Hestermann E.V., Geistlinger T.R., et al. Chromosome-wide mapping of estrogen receptor binding reveals long-range regulation requiring the forkhead protein FoxA1. Cell 2005, 122:33-43. 10.1016/j.cell.2005.05.008.
13. Carroll J.S., Meyer C.A., Song J., Li W., Geistlinger T.R., Eeckhoute J., Brodsky A.S., Keeton E.K., Fertuck K.C., Hall G.F., et al. Genome-wide analysis of estrogen receptor binding sites. Nature Genetics 2006, 38:1289-1297. 10.1038/ng1901.
14. Cirillo L.A., Lin F.R., Cuesta I., Friedman D., Jarnik M., Zaret K.S. Opening of compacted chromatin by early developmental transcription factors HNF3 (FoxA) and GATA-4. Molecular Cell 2002, 9:279-289.
15. Costa F.F. Non-coding RNAs: Meet thy masters. BioEssays 2010, 32:599-608. 10.1002/bies.200900112.
16. Cowper-Sal Lari R., Zhang X., Wright J.B., Bailey S.D., Cole M.D., Eeckhoute J., Moore J.H., Lupien M. Breast cancer risk-associated SNPs modulate the affinity of chromatin for FOXA1 and alter gene expression. Nature Genetics 2012, 10.1038/ng.2416.
17. Dawson M.A., Kouzarides T. Cancer epigenetics: from mechanism to therapy. Cell 2012, 150:12-27. 10.1016/j.cell.2012.06.013.
18. DiRenzo J., Shang Y., Phelan M., Sif S., Myers M., Kingston R., Brown M. BRG-1 is recruited to estrogen-responsive promoters and cooperates with factors involved in histone acetylation. Molecular and Cellular Biology 2000, 20:7541-7549.
19. Eeckhoute J., Keeton E.K., Lupien M., Krum S.A., Carroll J.S., Brown M. Positive cross-regulatory loop ties GATA-3 to estrogen receptor alpha expression in breast cancer. Cancer Research 2007, 67:6477-6483. 10.1158/0008-5472.CAN-07-0746.
20. Eeckhoute J., Lupien M., Meyer C.A., Verzi M.P., Shivdasani R.A., Liu X.S., Brown M. Cell-type selective chromatin remodeling defines the active subset of FOXA1-bound enhancers. Genome Research 2009, 19:372-380. 10.1101/gr.084582.108.
21. Ellis M.J., Ding L., Shen D., Luo J., Suman V.J., Wallis J.W., Van Tine B.A., Hoog J., Goiffon R.J., Goldstein T.C., et al. Whole-genome analysis informs breast cancer response to aromatase inhibition. Nature 2012, 486:353-360. 10.1038/nature11143.
22. ENCODE Project Consortium, Bernstein B.E., Birney E., Dunham I., Green E.D., Gunter C., Snyder M. An integrated encyclopedia of DNA elements in the human genome. Nature 2012, 489:57-74. 10.1038/nature11247.
23. Ernst J., Kellis M. Discovery and characterization of chromatin states for systematic annotation of the human genome. Nature Biotechnology 2010, 28:817-825. 10.1038/nbt.1662.
24. Ernst J., Kheradpour P., Mikkelsen T.S., Shoresh N., Ward L.D., Epstein C.B., Zhang X., Wang L., Issner R., Coyne M., et al. Mapping and analysis of chromatin state dynamics in nine human cell types. Nature 2011, 473:43-49. 10.1038/nature09906.
25. Feng S., Jacobsen S.E., Reik W. Epigenetic reprogramming in plant and animal development. Science (New York, NY) 2010, 330:622-627. 10.1126/science.1190614.
26. Foulds C.E., Tsimelzon A., Long W., Le A., Tsai S.Y., Tsai M.-J., O'Malley B.W. Research resource: expression profiling reveals unexpected targets and functions of the human steroid receptor RNA activator (SRA) gene. Molecular Endocrinology (Baltimore, Md.) 2010, 24:1090-1105. 10.1210/me.2009-0427.
27. Fullwood M.J., Liu M.H., Pan Y.F., Liu J., Xu H., Mohamed Y.B., Orlov Y.L., Velkov S., Ho A., Mei P.H., et al. An oestrogen-receptor-alpha-bound human chromatin interactome. Nature 2009, 462:58-64. 10.1038/nature08497.
28. Fussner E., Ching R.W., Bazett-Jones D.P. Living without 30nm chromatin fibers. Trends in Biochemical Sciences 2011, 36:1-6. 10.1016/j.tibs.2010.09.002.
29. Garcia-Bassets I., Kwon Y.-S., Telese F., Prefontaine G.G., Hutt K.R., Cheng C.S., Ju B.-G., Ohgi K.A., Wang J., Escoubet-Lozach L., et al. Histone methylation-dependent mechanisms impose ligand dependency for gene activation by nuclear receptors. Cell 2007, 128:505-518. 10.1016/j.cell.2006.12.038.
30. Gertz J., Reddy T.E., Varley K.E., Garabedian M.J., Myers R.M. Genistein and bisphenol A exposure cause estrogen receptor 1 to bind thousands of sites in a cell type-specific manner. Genome Research 2012, 10.1101/gr.135681.111.
31. Gupta R.A., Shah N., Wang K.C., Kim J., Horlings H.M., Wong D.J., Tsai M.-C., Hung T., Argani P., Rinn J.L., et al. Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature 2010, 464:1071-1076. 10.1038/nature08975.
32. Guttman M., Amit I., Garber M., French C., Lin M.F., Feldser D., Huarte M., Zuk O., Carey B.W., Cassady J.P., et al. Chromatin signature reveals over a thousand highly conserved large non-coding RNAs in mammals. Nature 2009, 458:223-227. 10.1038/nature07672.
33. Hall J.M., McDonnell D.P., Korach K.S. Allosteric regulation of estrogen receptor structure, function, and coactivator recruitment by different estrogen response elements. Molecular Endocrinology (Baltimore, Md.) 2002, 16:469-486.
34. Hargreaves D.C., Crabtree G.R. ATP-dependent chromatin remodeling: genetics, genomics and mechanisms. Cell Research 2011, 21:396-420. 10.1038/cr.2011.32.
35. He H.H., Meyer C.A., Shin H., Bailey S.T., Wei G., Wang Q., Zhang Y., Xu K., Ni M., Lupien M., et al. Nucleosome dynamics define transcriptional enhancers. Nature Genetics 2010, 42. 343-U101. 10.1038/ng.545.
36. He H.H., Meyer C.A., Chen M.W., Jordan V.C., Brown M., Liu X.S. Differential DNase I hypersensitivity reveals factor-dependent chromatin dynamics. Genome Research 2012, 22:1015-1025. 10.1101/gr.133280.111.
37. Heintzman N.D., Stuart R.K., Hon G., Fu Y., Ching C.W., Hawkins R.D., Barrera L.O., Van Calcar S., Qu C., Ching K.A., et al. Distinct and predictive chromatin signatures of transcriptional promoters and enhancers in the human genome. Nature Genetics 2007, 39:311-318. 10.1038/ng1966.
38. Heintzman N.D., Hon G.C., Hawkins R.D., Kheradpour P., Stark A., Harp L.F., Ye Z., Lee L.K., Stuart R.K., Ching C.W., et al. Histone modifications at human enhancers reflect global cell-type-specific gene expression. Nature 2009, 459:108-112. 10.1038/nature07829.
39. Henikoff S., Shilatifard A. Histone modification: cause or cog?. Trends in Genetics: TIG 2011, 27:389-396. 10.1016/j.tig.2011.06.006.
40. Holmes K.A., Hurtado A., Brown G.D., Launchbury R., Ross-Innes C.S., Hadfield J., Odom D.T., Carroll J.S. Breast Cancer Special Feature: transducin-like enhancer protein 1 mediates estrogen receptor binding and transcriptional activity in breast cancer cells. Proceedings of the National Academy of Sciences of the United States of America 2011, 10.1073/pnas.1018863108.
41. Hurtado A., Holmes K.A., Ross-Innes C.S., Schmidt D., Carroll J.S. FOXA1 is a key determinant of estrogen receptor function and endocrine response. Nature Genetics 2010, 43:27-33. 10.1038/ng.730.
42. Jenuwein T., Allis C.D. Translating the histone code. Science 2001, 293:1074-1080. 10.1126/science.1063127.
43. Jones P.A. Functions of DNA methylation: islands, start sites, gene bodies and beyond. Nature Reviews Genetics 2012, 13:484-492. 10.1038/nrg3230.
44. Joshi S.R., Ghattamaneni R.B., Scovell W.M. Expanding the paradigm for estrogen receptor binding and transcriptional activation. Molecular Endocrinology (Baltimore, Md.) 2011, 25:980-994. 10.1210/me.2010-0302.
45. Joshi S.R., Sarpong Y.C., Peterson R.C., Scovell W.M. Nucleosome dynamics: HMGB1 relaxes canonical nucleosome structure to facilitate estrogen receptor binding. Nucleic Acids Research 2012, 10.1093/nar/gks815.
46. Jozwik K.M., Carroll J.S. Pioneer factors in hormone-dependent cancers. Nature Reviews Cancer 2012, 10.1038/nrc3263.
47. Kangaspeska S., Stride B., Métivier R., Polycarpou-Schwarz M., Ibberson D., Carmouche R.P., Benes V., Gannon F., Reid G. Transient cyclical methylation of promoter DNA. Nature 2008, 452:112-115. 10.1038/nature06640.
48. Kim D., Lee J., Cheng D., Li J., Carter C., Richie E., Bedford M.T. Enzymatic activity is required for the in vivo functions of CARM1. The Journal of Biological Chemistry 2010, 285:1147-1152. 10.1074/jbc.M109.035865.
49. Klein-Hitpaß L., Schorpp M., Wagner U., Ryffel G.U. An estrogen-responsive element derived from the 5' flanking region of the Xenopus vitellogenin A2 gene functions in transfected human cells. Cell 1986, 46:1053-1061. 10.1016/0092-8674(86)90705-1.
50. Kong S.L., Li G., Loh S.L., Sung W.-K., Liu E.T. Cellular reprogramming by the conjoint action of ERα, FOXA1, and GATA3 to a ligand-inducible growth state. Molecular Systems Biology 2011, 7:526. 10.1038/msb.2011.59.
51. Kouzarides T. Chromatin modifications and their function. Cell 2007, 128:693-705. 10.1016/j.cell.2007.02.005.
52. Kraus W.L., Kadonaga J.T. P300 and estrogen receptor cooperatively activate transcription via differential enhancement of initiation and reinitiation. Genes & Development 1998, 12:331-342.
53. Krum S.A., Miranda-Carboni G.A., Lupien M., Eeckhoute J., Carroll J.S., Brown M. Unique ERalpha cistromes control cell type-specific gene regulation. Molecular Endocrinology (Baltimore, Md.) 2008, 22:2393-2406. 10.1210/me.2008-0100.
54. Kumar V., Chambon P. The estrogen receptor binds tightly to its responsive element as a ligand-induced homodimer. Cell 1988, 55:145-156.
55. Kumar V., Green S., Stack G., Berry M., Jin J.R., Chambon P. Functional domains of the human estrogen receptor. Cell 1987, 51:941-951.
56. Laganière J., Deblois G., Lefebvre C., Bataille A.R., Robert F., Giguère V. From the cover: location analysis of estrogen receptor alpha target promoters reveals that FOXA1 defines a domain of the estrogen response. Proceedings of the National Academy of Sciences of the United States of America 2005, 102:11651-11656. 10.1073/pnas.0505575102.
57. Lan X., Witt H., Katsumura K., Ye Z., Wang Q., Bresnick E.H., Farnham P.J., Jin V.X. Integration of Hi-C and ChIP-seq data reveals distinct types of chromatin linkages. Nucleic Acids Research 2012, 40:7690-7704. 10.1093/nar/gks501.
58. Lanz R.B., McKenna N.J., Onate S.A., Albrecht U., Wong J., Tsai S.Y., Tsai M.J., O'Malley B.W. A steroid receptor coactivator, SRA, functions as an RNA and is present in an SRC-1 complex. Cell 1999, 97:17-27.
59. Li G., Ruan X., Auerbach R.K., Sandhu K.S., Zheng M., Wang P., Poh H.M., Goh Y., Lim J., Zhang J., et al. Extensive promoter-centered chromatin interactions provide a topological basis for transcription regulation. Cell 2012, 148:84-98. 10.1016/j.cell.2011.12.014.
60. Li Z., Gadue P., Chen K., Jiao Y., Tuteja G., Schug J., Li W., Kaestner K.H. Foxa2 and H2A.Z mediate nucleosome depletion during embryonic stem cell differentiation. Cell 2012, 151:1608-1616. 10.1016/j.cell.2012.11.018.
61. Lieberman-Aiden E., van Berkum N.L., Williams L., Imakaev M., Ragoczy T., Telling A., Amit I., Lajoie B.R., Sabo P.J., Dorschner M.O., et al. Comprehensive mapping of long-range interactions reveals folding principles of the human genome. Science (New York, NY) 2009, 326:289-293. 10.1126/science.1181369.
62. Lin C.-Y., Vega V.B., Thomsen J.S., Zhang T., Kong S.L., Xie M., Chiu K.P., Lipovich L., Barnett D.H., Stossi F., et al. Whole-genome cartography of estrogen receptor alpha binding sites. PLoS Genetics 2007, 3:e87. 10.1371/journal.pgen.0030087.
63. Liu X.-F., Bagchi M.K. Recruitment of distinct chromatin-modifying complexes by tamoxifen-complexed estrogen receptor at natural target gene promoters in vivo. The Journal of Biological Chemistry 2004, 279:15050-15058. 10.1074/jbc.M311932200.
64. Luger K., Mäder A.W., Richmond R.K., Sargent D.F., Richmond T.J. Crystal structure of the nucleosome core particle at 2.8A resolution. Nature 1997, 389:251-260. 10.1038/38444.
65. Lupien M., Eeckhoute J., Meyer C.A., Wang Q., Zhang Y., Li W., Carroll J.S., Liu X.S., Brown M. FoxA1 translates epigenetic signatures into enhancer-driven lineage-specific transcription. Cell 2008, 132:958-970. 10.1016/j.cell.2008.01.018.
66. Lupien M., Eeckhoute J., Meyer C.A., Krum S.A., Rhodes D.R., Liu X.S., Brown M. Coactivator function defines the active estrogen receptor alpha cistrome. Molecular and Cellular Biology 2009, 29:3413-3423. 10.1128/MCB.00020-09.
67. Lupien M., Meyer C.A., Bailey S.T., Eeckhoute J., Cook J., Westerling T., Zhang X., Carroll J.S., Rhodes D.R., Liu X.S., et al. Growth factor stimulation induces a distinct ER(alpha) cistrome underlying breast cancer endocrine resistance. Genes & Development 2010, 24:2219-2227. 10.1101/gad.1944810.
68. Magnani L., Ballantyne E.B., Zhang X., Lupien M. PBX1 genomic pioneer function drives ERα signaling underlying progression in breast cancer. PLoS Genetics 2011, 7:e1002368. 10.1371/journal.pgen.1002368.
69. Magnani L., Eeckhoute J., Lupien M. Pioneer factors: directing transcriptional regulators within the chromatin environment. Trends in Genetics: TIG 2011, 27:465-474. 10.1016/j.tig.2011.07.002.
70. Magnani L., Stoeck A., Zhang X., Lanczky A., Mirabella A.C., Wang T.-L., Györffy B., Lupien M. Genome-wide reprogramming of the chromatin landscape underlies endocrine therapy resistance in breast cancer. Proceedings of the National Academy of Sciences of the United States of America 2013, 10.1073/pnas.1219992110.
71. Métivier R., Penot G., Hübner M.R., Reid G., Brand H., Kos M., Gannon F. Estrogen receptor-alpha directs ordered, cyclical, and combinatorial recruitment of cofactors on a natural target promoter. Cell 2003, 115:751-763.
72. Métivier R., Gallais R., Tiffoche C., Le Péron C., Jurkowska R.Z., Carmouche R.P., Ibberson D., Barath P., Demay F., Reid G., et al. Cyclical DNA methylation of a transcriptionally active promoter. Nature 2008, 452:45-50. 10.1038/nature06544.
73. Mikkelsen T.S., Ku M., Jaffe D.B., Issac B., Lieberman E., Giannoukos G., Alvarez P., Brockman W., Kim T.-K., Koche R.P., et al. Genome-wide maps of chromatin state in pluripotent and lineage-committed cells. Nature 2007, 448:553-560. 10.1038/nature06008.
74. Mo R. Identification of the MLL2 Complex as a Coactivator for Estrogen Receptor. The Journal of Biological Chemistry 2006, 281:15714-15720. 10.1074/jbc.M513245200.
75. Neph S., Vierstra J., Stergachis A.B., Reynolds A.P., Haugen E., Vernot B., Thurman R.E., John S., Sandstrom R., Johnson A.K., et al. An expansive human regulatory lexicon encoded in transcription factor footprints. Nature 2012, 489:83-90. 10.1038/nature11212.
76. Pan Y.F., Wansa K.D.S.A., Liu M.H., Zhao B., Hong S.Z., Tan P.Y., Lim K.S., Bourque G., Liu E.T., Cheung E. Regulation of estrogen receptor-mediated long range transcription via evolutionarily conserved distal response elements. The Journal of Biological Chemistry 2008, 283:32977-32988. 10.1074/jbc.M802024200.
77. Perillo B., Ombra M.N., Bertoni A., Cuozzo C., Sacchetti S., Sasso A., Chiariotti L., Malorni A., Abbondanza C., Avvedimento E.V. DNA oxidation as triggered by H3K9me2 demethylation drives estrogen-induced gene expression. Science (New York, NY) 2008, 319:202-206. 10.1126/science.1147674.
78. Pomerantz M.M., Ahmadiyeh N., Jia L., Herman P., Verzi M.P., Doddapaneni H., Beckwith C.A., Chan J.A., Hills A., Davis M., et al. The 8q24 cancer risk variant rs6983267 shows long-range interaction with MYC in colorectal cancer. Nature Genetics 2009, 41:882-884. 10.1038/ng.403.
79. Reid G., Hübner M.R., Métivier R., Brand H., Denger S., Manu D., Beaudouin J., Ellenberg J., Gannon F. Cyclic, proteasome-mediated turnover of unliganded and liganded ERalpha on responsive promoters is an integral feature of estrogen signaling. Molecular Cell 2003, 11:695-707.
80. Renoir J.-M. Estradiol receptors in breast cancer cells: associated co-factors as targets for new therapeutic approaches. Steroids 2012, 77:1249-1261. 10.1016/j.steroids.2012.07.019.
81. Rodríguez-Paredes M., Esteller M. Cancer epigenetics reaches mainstream oncology. Nature Medicine 2011, 17:330-339. 10.1038/nm.2305.
82. Ross-Innes C.S., Stark R., Teschendorff A.E., Holmes K.A., Ali H.R., Dunning M.J., Brown G.D., Gojis O., Ellis I.O., Green A.R., et al. Differential oestrogen receptor binding is associated with clinical outcome in breast cancer. Nature 2012, 481:389-393. 10.1038/nature10730.
83. Salmena L., Poliseno L., Tay Y., Kats L., Pandolfi P.P. A ceRNA hypothesis: the Rosetta Stone of a hidden RNA language?. Cell 2011, 146:353-358. 10.1016/j.cell.2011.07.014.
84. Sanchez R., Zhou M.-M. The role of human bromodomains in chromatin biology and gene transcription. Current Opinion in Drug Discovery & Development 2009, 12:659-665.
85. Sandelin A., Alkema W., Engström P., Wasserman W.W., Lenhard B. JASPAR: an open-access database for eukaryotic transcription factor binding profiles. Nucleic Acids Research 2004, 32:D91-D94. 10.1093/nar/gkh012.
86. Sanyal A., Lajoie B.R., Jain G., Dekker J. The long-range interaction landscape of gene promoters. Nature 2012, 489:109-113. 10.1038/nature11279.
87. Schneider R., Grosschedl R. Dynamics and interplay of nuclear architecture, genome organization, and gene expression. Genes & Development 2007, 21:3027-3043. 10.1101/gad.1604607.
88. Sekiya T., Muthurajan U.M., Luger K., Tulin A.V., Zaret K.S. Nucleosome-binding affinity as a primary determinant of the nuclear mobility of the pioneer transcription factor FoxA. Genes & Development 2009, 23:804-809. 10.1101/gad.1775509.
89. Sérandour A.A., Avner S., Percevault F., Demay F., Bizot M., Lucchetti-Miganeh C., Barloy-Hubler F., Brown M., Lupien M., Métivier R., et al. Epigenetic switch involved in activation of pioneer factor FOXA1-dependent enhancers. Genome Research 2011, 21:555-565. 10.1101/gr.111534.110.
90. Shang Y., Hu X., DiRenzo J., Lazar M.A., Brown M. Cofactor dynamics and sufficiency in estrogen receptor-regulated transcription. Cell 2000, 103:843-852.
91. Sheffery M., Rifkind R.A., Marks P.A. Murine erythroleukemia cell differentiation: DNase I hypersensitivity and DNA methylation near the globin genes. Proceedings of the National Academy of Sciences of the United States of America 1982, 79:1180-1184.
92. Shen Y., Yue F., McCleary D.F., Ye Z., Edsall L., Kuan S., Wagner U., Dixon J., Lee L., Lobanenkov V.V., et al. A map of the cis-regulatory sequences in the mouse genome. Nature 2012, 488:116-120. 10.1038/nature11243.
93. Shi Y., Lan F., Matson C., Mulligan P., Whetstine J.R., Cole P.A., Casero R.A., Shi Y. Histone demethylation mediated by the nuclear amine oxidase homolog LSD1. Cell 2004, 119:941-953. 10.1016/j.cell.2004.12.012.
94. Shi, L., Sun, L., Li, Q., Liang, J., Yu, W., Yi, X., Yang, X., Li, Y., Han, X., Zhang, Y. et al. 2011. Histone demethylase JMJD2B coordinates H3K4/H3K9 methylation and promotes hormonally responsive breast, carcinogenesis. Proc Natl Acad Sci U S A, 108, 7541-7546. doi: doi:10.1073/pnas.1017374108.
95. Smale S.T. Pioneer factors in embryonic stem cells and differentiation. Current Opinion in Genetics & Development 2010, 20:519-526. 10.1016/j.gde.2010.06.010.
96. Smith B.C., Denu J.M. Chemical mechanisms of histone lysine and arginine modifications. Biochimica Et Biophysica Acta 2009, 1789:45-57. 10.1016/j.bbagrm.2008.06.005.
97. Song L., Zhang Z., Grasfeder L.L., Boyle A.P., Giresi P.G., Lee B.-K., Sheffield N.C., Gräf S., Huss M., Keefe D., et al. Open chromatin defined by DNaseI and FAIRE identifies regulatory elements that shape cell-type identity. Genome Research 2011, 21:1757-1767. 10.1101/gr.121541.111.
98. Staynov D.Z. DNase I digestion reveals alternating asymmetrical protection of the nucleosome by the higher order chromatin structure. Nucleic Acids Research 2000, 28:3092-3099.
99. Stephens P.J., Tarpey P.S., Davies H., Van Loo P., Greenman C., Wedge D.C., Nik-Zainal S., Martin S., Varela I., Bignell G.R., et al. The landscape of cancer genes and mutational processes in breast cancer. Nature 2012, 486:400-404. 10.1038/nature11017.
100. Tan S.K., Lin Z.H., Chang C.W., Varang V., Chng K.R., Pan Y.F., Yong E.L., Sung W.-K., Sung W.K., Cheung E. AP-2γ regulates oestrogen receptor-mediated long-range chromatin interaction and gene transcription. The EMBO Journal 2011, 30:2569-2581. 10.1038/emboj.2011.151.
101. Theodorou V., Stark R., Menon S., Carroll J.S. GATA3 acts upstream of FOXA1 in mediating ESR1 binding by shaping enhancer accessibility. Genome Research 2012, 10.1101/gr.139469.112.
102. Thurman R.E., Rynes E., Humbert R., Vierstra J., Maurano M.T., Haugen E., Sheffield N.C., Stergachis A.B., Wang H., Vernot B., et al. The accessible chromatin landscape of the human genome. Nature 2012, 489:75-82. 10.1038/nature11232.
103. Tuupanen S., Turunen M., Lehtonen R., Hallikas O., Vanharanta S., Kivioja T., Björklund M., Wei G., Yan J., Niittymäki I., et al. The common colorectal cancer predisposition SNP rs6983267 at chromosome 8q24 confers potential to enhanced Wnt signaling. Nature Genetics 2009, 41:885-890. 10.1038/ng.406.
104. Vakoc C.R., Letting D.L., Gheldof N., Sawado T., Bender M.A., Groudine M., Weiss M.J., Dekker J., Blobel G.A. Proximity among distant regulatory elements at the beta-globin locus requires GATA-1 and FOG-1. Molecular Cell 2005, 17:453-462. 10.1016/j.molcel.2004.12.028.
105. Wang Q., Carroll J.S., Brown M. Spatial and temporal recruitment of androgen receptor and its coactivators involves chromosomal looping and polymerase tracking. Molecular Cell 2005, 19:631-642. 10.1016/j.molcel.2005.07.018.
106. Wang Q., Li W., Zhang Y., Yuan X., Xu K., Yu J., Chen Z., Beroukhim R., Wang H., Lupien M., et al. Androgen receptor regulates a distinct transcription program in androgen-independent prostate cancer. Cell 2009, 138:245-256. 10.1016/j.cell.2009.04.056.
107. Wang J., Zhuang J., Iyer S., Lin X., Whitfield T.W., Greven M.C., Pierce B.G., Dong X., Kundaje A., Cheng Y., et al. Sequence features and chromatin structure around the genomic regions bound by 119 human transcription factors. Genome Research 2012, 22:1798-1812. 10.1101/gr.139105.112.
108. Welboren W.-J., van Driel M.A., Janssen-Megens E.M., van Heeringen S.J., Sweep F.C., Span P.N., Stunnenberg H.G. ChIP-Seq of ERalpha and RNA polymerase II defines genes differentially responding to ligands. The EMBO Journal 2009, 28:1418-1428. 10.1038/emboj.2009.88.
109. Wingender E. Compilation of transcription regulating proteins. Nucleic Acids Research 1988, 16:1879-1902.
110. Wright J.B., Brown S.J., Cole M.D. Upregulation of c-MYC in cis through a large chromatin loop linked to a cancer risk-associated single-nucleotide polymorphism in colorectal cancer cells. Molecular and Cellular Biology 2010, 30:1411-1420. 10.1128/MCB.01384-09.
111. Wu J., Xu W. Histone H3R17me2a mark recruits human RNA polymerase-associated factor 1 complex to activate transcription. Proceedings of the National Academy of Sciences of the United States of America 2012, 109:5675-5680. 10.1073/pnas.1114905109.
112. Wu J.I., Lessard J., Crabtree G.R. Understanding the words of chromatin regulation. Cell 2009, 136:200-206. 10.1016/j.cell.2009.01.009.
113. Xiao R., Sun D., Ayers S., Xi Y., Li W., Baxter J.D., Moore D.D. Research resource: the estrogen receptor α cistrome defined by DamIP. Molecular Endocrinology (Baltimore, Md.) 2012, 26:349-357. 10.1210/me.2011-1080.
114. Yap K.L., Zhou M.-M. Structure and mechanisms of lysine methylation recognition by the chromodomain in gene transcription. Biochemistry 2011, 50:1966-1980. 10.1021/bi101885m.
115. Zaret K.S., Carroll J.S. Pioneer transcription factors: establishing competence for gene expression. Genes & Development 2011, 25:2227-2241. 10.1101/gad.176826.111.
116. Zhang X., Cowper-Sal Lari R., Bailey S.D., Moore J.H., Lupien M. Integrative functional genomics identifies an enhancer looping to the SOX9 gene disrupted by the 17q24.3 prostate cancer risk locus. Genome Research 2012, 22:1437-1446. 10.1101/gr.135665.111.
117. Zhang X., Bolt M., Guertin M.J., Chen W., Zhang S., Cherrington B.D., Slade D.J., Dreyton C.J., Subramanian V., Bicker K.L., et al. Peptidylarginine deiminase 2-catalyzed histone H3 arginine 26 citrullination facilitates estrogen receptor α target gene activation. Proceedings of the National Academy of Sciences of the United States of America 2012, 109:13331-13336. 10.1073/pnas.1203280109.
118. Zwart W., Theodorou V., Kok M., Canisius S., Linn S., Carroll J.S. Oestrogen receptor-co-factor-chromatin specificity in the transcriptional regulation of breast cancer. The EMBO Journal 2011, 30:4764-4776. 10.1038/emboj.2011.368.